190 related articles for article (PubMed ID: 24220766)
1. Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?
de Vries MG; Ekkelenkamp MB; Peters EJ
Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):453-6. PubMed ID: 24220766
[TBL] [Abstract][Full Text] [Related]
2. Empirical Antibiotic Treatment in Diabetic Foot Infection: A Study Focusing on the Culture and Antibiotic Sensitivity in a Population From Southern China.
Wu WX; Liu D; Wang YW; Wang C; Yang C; Liu XZ; Mai LF; Ren M; Yan L
Int J Low Extrem Wounds; 2017 Sep; 16(3):173-182. PubMed ID: 28836481
[TBL] [Abstract][Full Text] [Related]
3. [Infections in diabetic foot. Choice of empirical antibiotic regimen].
Carro GV; Carlucci E; Priore G; Gette F; Llanos MLA; Dicatarina Losada MV; Noli ML; Amato PS
Medicina (B Aires); 2019; 79(3):167-173. PubMed ID: 31284250
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic therapy for diabetic foot infections in a tertiary care hospital in Jakarta, Indonesia.
Radji M; Putri CS; Fauziyah S
Diabetes Metab Syndr; 2014; 8(4):221-4. PubMed ID: 25311820
[TBL] [Abstract][Full Text] [Related]
5. Management and outcome of severe diabetic foot infections.
Diamantopoulos EJ; Haritos D; Yfandi G; Grigoriadou M; Margariti G; Paniara O; Raptis SA
Exp Clin Endocrinol Diabetes; 1998; 106(4):346-52. PubMed ID: 9792469
[TBL] [Abstract][Full Text] [Related]
6. Diabetic foot infections: stepwise medical and surgical management.
Armstrong DG; Lipsky BA
Int Wound J; 2004 Jun; 1(2):123-32. PubMed ID: 16722884
[TBL] [Abstract][Full Text] [Related]
7. Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA.
Mutonga DM; Mureithi MW; Ngugi NN; Otieno FCF
BMC Res Notes; 2019 Apr; 12(1):244. PubMed ID: 31036061
[TBL] [Abstract][Full Text] [Related]
8. Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Park KH; Kim DY; Lee YM; Lee MS; Kang KC; Lee JH; Park SY; Moon C; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Ryu BH; Bae IG; Cho OH
PLoS One; 2019; 14(2):e0211888. PubMed ID: 30735536
[TBL] [Abstract][Full Text] [Related]
9. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.
de Lalla F; Pellizzer G; Strazzabosco M; Martini Z; Du Jardin G; Lora L; Fabris P; Benedetti P; Erle G
Antimicrob Agents Chemother; 2001 Apr; 45(4):1094-8. PubMed ID: 11257020
[TBL] [Abstract][Full Text] [Related]
10. Microbial profile of diabetic foot infections in Trinidad and Tobago.
Islam S; Cawich SO; Budhooram S; Harnarayan P; Mahabir V; Ramsewak S; Naraynsingh V
Prim Care Diabetes; 2013 Dec; 7(4):303-8. PubMed ID: 23742849
[TBL] [Abstract][Full Text] [Related]
11. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
[TBL] [Abstract][Full Text] [Related]
12. The bacteriology of diabetic foot ulcers in Port Harcourt, Nigeria.
Unachukwu CN; Obunge OK; Odia OJ
Niger J Med; 2005; 14(2):173-6. PubMed ID: 16083241
[TBL] [Abstract][Full Text] [Related]
13. Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection?
Lebowitz D; Gariani K; Kressmann B; Dach EV; Huttner B; Bartolone P; Lê N; Mohamad M; Lipsky BA; Uçkay I
Int J Infect Dis; 2017 Jun; 59():61-64. PubMed ID: 28450198
[TBL] [Abstract][Full Text] [Related]
14. Diabetic Foot Infection: Causative Pathogens and Empiric Antibiotherapy Considerations-The Experience of a Tertiary Center.
Neves JM; Duarte B; Pinto M; Formiga A; Neves J
Int J Low Extrem Wounds; 2019 Jun; 18(2):122-128. PubMed ID: 31035803
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of diabetic foot infections.
Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Analysis of Antibiotic Usage in Diabetic Foot Infections Against Healing Time.
Kruszewska K; Wesolowska-Gorniak K; Czarkowska-Paczek B
J Foot Ankle Surg; 2021; 60(5):902-907. PubMed ID: 33820683
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
Lobmann R; Ambrosch A; Seewald M; Dietlein M; Zink K; Kullmann KH; Lehnert H
Diabetes Nutr Metab; 2004 Jun; 17(3):156-62. PubMed ID: 15334793
[TBL] [Abstract][Full Text] [Related]
18. Conservative management of diabetic foot osteomyelitis.
Acharya S; Soliman M; Egun A; Rajbhandari SM
Diabetes Res Clin Pract; 2013 Sep; 101(3):e18-20. PubMed ID: 23850116
[TBL] [Abstract][Full Text] [Related]
19. Bacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia.
Atlaw A; Kebede HB; Abdela AA; Woldeamanuel Y
Front Endocrinol (Lausanne); 2022; 13():987487. PubMed ID: 36120451
[TBL] [Abstract][Full Text] [Related]
20. Microbiology of diabetic foot infections in three district hospital in Malaysia and comparison with South East Asian Countries.
Kow RY; Low CL; Ruben JK; Zaharul Azri WMZ; Mor Japar Khan ESK
Med J Malaysia; 2019 Oct; 74(5):394-399. PubMed ID: 31649215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
